Data / Drug companies / Neomycin sulfate, polymyxin b sulfate and hydrocortisone
Neomycin sulfate, polymyxin b sulfate and hydrocortisone: 8 companies and 14 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Neomycin sulfate, polymyxin b sulfate and hydrocortisone is listed in the FDA National Drug Code Directory by 8 companies, with 14 products in commercial distribution. 14 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension/ drops; suspension; solution, and the newest product started marketing on September 30, 2025.
The request: Get every company that lists neomycin sulfate, polymyxin b sulfate and hydrocortisone in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 8
- Products
- 14
- Generic (ANDA) products
- 14 (100.0%)
- Application numbers
- 5
- Routes
- Auricular (otic), Ophthalmic
- Brand names
- Neomycin and Polymyxin B Sulfates and Hydrocortisone, Neomycin and Polymyxin B Sulfates and Hydrocortisone
- openFDA record search
- api.fda.gov
Companies that list neomycin sulfate, polymyxin b sulfate and hydrocortisone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Proficient Rx LP | 3 | suspension/ drops; solution | Generic drugs (ANDA) | March 18, 2003 |
| Sandoz Inc | 3 | suspension; solution | Generic drugs (ANDA) | May 9, 2003 |
| A-S Medication Solutions | 2 | suspension/ drops; suspension | Generic drugs (ANDA) | March 17, 2003 |
| Preferred Pharmaceuticals Inc. | 2 | suspension; suspension/ drops | Generic drugs (ANDA) | February 3, 2022 |
| Amneal Pharmaceuticals NY LLC | 1 | suspension/ drops | Generic drugs (ANDA) | September 30, 2025 |
| Bausch & Lomb Incorporated | 1 | suspension/ drops | Generic drugs (ANDA) | August 28, 1996 |
| Bryant Ranch Prepack | 1 | suspension | Generic drugs (ANDA) | March 17, 2003 |
| NuCare Pharmaceuticals,Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | August 28, 1996 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension/ drops | 6 | 42.9% |
| Suspension | 6 | 42.9% |
| Solution | 2 | 14.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Aminoglycoside Antibacterial | 14 |
| Corticosteroid | 14 |
| Polymyxin-class Antibacterial | 14 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.